Severe edema and blood blisters of the lower extremities caused by sitagliptin, a dipeptidyl peptidase-4 inhibitor

被引：0
|
作者：
Maita, Hiroki [1 ]
Kobayashi, Tadashi [2 ]
Akimoto, Takashi [2 ]
Osawa, Hiroshi [2 ]
Kato, Hiroyuki [1 ,2 ,3 ]
机构：
[1] Hirosaki Univ, Dev Community Healthcare, Grad Sch Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Dept Gen Med, Sch Med Hosp, Aomori, Japan
[3] Hirosaki Univ, Gen Med, Grad Sch Med, Aomori, Japan
来源：
JOURNAL OF GENERAL AND FAMILY MEDICINE | 2022年 / 23卷 / 02期
关键词：
blister; dipeptidyl peptidase-4 inhibitor; edema; sitagliptin;
D O I：
10.1002/jgf2.502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
    Hermansen, K.
    Kipnes, M.
    Luo, E.
    Fanurik, D.
    Khatami, H.
    Stein, P.
    DIABETES OBESITY & METABOLISM, 2007, 9 (05) : 733 - 745
  • [42] Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Exhibits Antioxidant Mechanism for Abrogation of Cyclophosphamide-Induced Cardiac Damage and Oxidative Hepatorenal Toxicity in Rats
    Famurewa, Ademola C.
    Aja, Patrick M.
    Medewase, John O.
    Abi, Innocent
    Ogbonna, Okoro C.
    Ofor, Casimir C.
    Nwonuma, Charles O.
    Asogwa, Nnaemeka T.
    Erejuwa, Omotayo O.
    DRUG RESEARCH, 2022, 72 (07) : 396 - 403
  • [43] C-Peptide Levels Predict the Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Therapy
    Demir, Sevin
    Temizkan, Sule
    Sargin, Mehmet
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [44] Multiple-dose administration of sitagliptin, a dipeptidyl peptidase-4 inhibitor, does not alter the single-dose pharmacokinetics of rosiglitazone in healthy subjects
    Mistry, Goutam C.
    Bergman, Arthur J.
    Luo, Wen-Lin
    Cilissen, Caroline
    Haazen, Wouter
    Davies, Michael J.
    Gottesdiener, Keith M.
    Wagner, John A.
    Herman, Gary A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (02) : 159 - 164
  • [45] Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
    Terawaki, Yuichi
    Nomiyama, Takashi
    Kawanami, Takako
    Hamaguchi, Yuriko
    Takahashi, Hiroyuki
    Tanaka, Tomoko
    Murase, Kunitaka
    Nagaishi, Ryoko
    Tanabe, Makito
    Yanase, Toshihiko
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [46] Suppression of Abdominal Aortic Aneurysm Formation in Mice by Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor
    Takahara, Yusuke
    Tokunou, Tomotake
    Ichiki, Toshihiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (08) : 698 - 708
  • [47] Dipeptidyl peptidase-4 inhibitor-associated cutaneous eruptions: a retrospective observational study
    Duraisamy, Prasanna
    Jagadeesan, Soumya
    Eapen, Malini
    Thomas, Jacob
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (07) : 1283 - 1290
  • [48] Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E-deficient mice
    Li, Bo
    Luo, Yan Rong
    Zhang, Qian
    Fu, Shi Hui
    Chen, Yun Dai
    Tian, Jing Wen
    Guo, Yi
    VASCULAR PHARMACOLOGY, 2021, 140
  • [49] A Case of Euglycemic Diabetic Ketoacidosis (DKA), Influenza, and a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
    Jeong, Su Hyun
    Vorachitti, Merica
    Fuentes, Fernando
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [50] Effect of a single cyclosporine dose on the single-dose pharmacokinetics of sitagliptin (MK-0431), a dipeptidyl peptidase-4 inhibitor, in healthy male subjects
    Krishna, Rajesh
    Bergman, Arthur
    Larson, Patrick
    Cote, Josee
    Lasseter, Kenneth
    Dilzer, Stacey
    Wang, Amy
    Zeng, Wei
    Chen, Li
    Wagner, John
    Herman, Gary
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (02) : 165 - 174
12345